These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2998314)

  • 1. Melphalan-resistant lymphoblastoid cell lines established from patients with ovarian cancer treated with cross-linking agents.
    Maynard K; Musk P; Daunter B; Khoo SK; Parsons PG
    Aust J Exp Biol Med Sci; 1985 Jun; 63 ( Pt 3)():333-41. PubMed ID: 2998314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
    Bramson J; McQuillan A; Aubin R; Alaoui-Jamali M; Batist G; Christodoulopoulos G; Panasci LC
    Mutat Res; 1995 May; 336(3):269-78. PubMed ID: 7739615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation.
    Belfi CA; Chatterjee S; Gosky DM; Berger SJ; Berger NA
    Biochem Biophys Res Commun; 1999 Apr; 257(2):361-8. PubMed ID: 10198218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt's lymphoma cell lines.
    Cariati R; Zancai P; Quaia M; Cutrona G; Giannini F; Rizzo S; Boiocchi M; Dolcetti R
    Int J Cancer; 2000 May; 86(3):375-84. PubMed ID: 10760826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between resistance to cross-linking agents and glutathione metabolism, aldehyde dehydrogenase isozymes and adenovirus replication in human tumour cell lines.
    Parsons PG; Lean J; Kable EP; Favier D; Khoo SK; Hurst T; Holmes RS; Bellet AJ
    Biochem Pharmacol; 1990 Dec; 40(12):2641-9. PubMed ID: 2260988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-restricted presentation of WT1 tumor antigen in B-lymphoblastoid cell lines established using a maxi-EBV system.
    Kanda T; Ochi T; Fujiwara H; Yasukawa M; Okamoto S; Mineno J; Kuzushima K; Tsurumi T
    Cancer Gene Ther; 2012 Aug; 19(8):566-71. PubMed ID: 22722376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease and age-matched controls.
    Ounanian A; Guilbert B; Seigneurin JM
    Mech Ageing Dev; 1992 Mar; 63(1):105-16. PubMed ID: 1318479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.
    Green JA; Vistica DT; Young RC; Hamilton TC; Rogan AM; Ozols RF
    Cancer Res; 1984 Nov; 44(11):5427-31. PubMed ID: 6488194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q; Bianchi P; Bezwoda WR
    Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytotoxicity, DNA crosslinking ability and DNA sequence selectivity of the aniline mustards melphalan, chlorambucil and 4-[bis(2-chloroethyl)amino] benzoic acid.
    Sunters A; Springer CJ; Bagshawe KD; Souhami RL; Hartley JA
    Biochem Pharmacol; 1992 Jul; 44(1):59-64. PubMed ID: 1632839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melphalan resistant human ovarian tumour cells are cross-resistant to photons, but not to high LET neutrons.
    Britten RA; Warenius HM; White R; Browning PG; Green JA
    Radiother Oncol; 1990 Aug; 18(4):357-63. PubMed ID: 2244022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation with allogeneic Epstein-Barr virus-transformed lymphoblastoid cell lines generates HLA class I-specific CTLs with different target cell avidity.
    Torsteinsdottir S; Cuomo L; Klein E; Masucci MG
    Cell Immunol; 1991 Oct; 137(2):501-13. PubMed ID: 1654213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of EBV-Infected Lymphoblastoid Cell Lines.
    Nagy N
    Methods Mol Biol; 2017; 1532():57-64. PubMed ID: 27873266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro establishment of tumorigenic human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
    Takahashi T; Kawabe T; Okazaki Y; Itoh C; Noda K; Tajima M; Satoh M; Goto M; Mitsui Y; Tahara H; Ide T; Furuichi Y; Sugimoto M
    DNA Cell Biol; 2003 Nov; 22(11):727-35. PubMed ID: 14659045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cytokine production and growth inhibition of lymphoblastoid cell lines by CD4+ T cells from Epstein-Barr virus (EBV) seropositive donors.
    Wilson AD; Hopkins JC; Morgan AJ
    Clin Exp Immunol; 2001 Oct; 126(1):101-10. PubMed ID: 11678905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the expression of CD4 and the level of CD4 mRNA in human B-cell lines.
    Yu Y; Rabinowitz R; Steinitz M; Schlesinger M
    Cell Immunol; 2002 Jan; 215(1):78-86. PubMed ID: 12142039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic reversal of drug resistance in ovarian cancer.
    Ozols RF
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):7-11. PubMed ID: 4048979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of inflammatory cytokines by Epstein-Barr virus (EBV)-infected lymphoblastoid cell lines spontaneously originated from the peripheral blood of patients with human immunodeficiency virus (HIV) infection.
    Roncella S; Baldi L; Cutrona G; Viale M; Rizzo F; Gasco M; Ferrarini M; Pistoia V
    Clin Immunol Immunopathol; 1995 Nov; 77(2):162-71. PubMed ID: 7586723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.
    Behrens BC; Hamilton TC; Masuda H; Grotzinger KR; Whang-Peng J; Louie KG; Knutsen T; McKoy WM; Young RC; Ozols RF
    Cancer Res; 1987 Jan; 47(2):414-8. PubMed ID: 3539322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.